Return to Article Details USE OF DUAL AND TRIPLE INCRETIN AGONISTS (TIRZEPATIDE AND RETATRUTIDE) IN THE TREATMENT OF OBESITY AND TYPE 2 DIABETES MELLITUS Download Download PDF